当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析 - 现金流量表

上海医药

(601607)

  

流通市值:500.10亿  总市值:664.91亿
流通股本:27.89亿   总股本:37.08亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金223,734,692,550.11148,688,702,663.6970,910,161,157.29301,138,074,959.71
  收到的税费返还152,560,975.79106,985,906.8838,238,102.29157,075,769.86
  收到其他与经营活动有关的现金3,582,188,850.872,295,146,319.361,393,974,548.043,355,474,894.37
  经营活动现金流入小计227,469,442,376.77151,090,834,889.9372,342,373,807.62304,650,625,623.94
  购买商品、接受劳务支付的现金199,383,937,006.94133,530,822,206.4165,775,005,547.17268,134,361,085.34
  支付给职工以及为职工支付的现金7,293,925,442.425,836,065,054.482,607,855,464.0410,639,199,652.27
  支付的各项税费5,827,774,466.53,962,697,333.331,773,546,369.287,327,044,163.21
  支付其他与经营活动有关的现金12,613,995,295.326,771,993,306.824,390,282,030.3412,722,762,991.79
  经营活动现金流出小计225,119,632,211.18150,101,577,901.0474,546,689,410.83298,823,367,892.61
  经营活动产生的现金流量净额2,349,810,165.59989,256,988.89-2,204,315,603.215,827,257,731.33
二、投资活动产生的现金流量:
  收回投资收到的现金50,949,303,686.7636,312,602,00015,723,939,00047,809,428,496.41
  取得投资收益收到的现金366,774,426.61169,259,831.4538,474,527.841,346,951,721.68
  处置固定资产、无形资产和其他长期资产收回的现金净额79,911,584.0567,276,784.1912,714,792.84244,660,546.13
  处置子公司及其他营业单位收到的现金净额24,108,575.1216,865,471.7915,892,367.13-
  收到的其他与投资活动有关的现金1,388,824,8001,125,180,875.51667,562,153.291,032,193,865.93
  投资活动现金流入小计52,808,923,072.5437,691,184,962.9416,458,582,841.150,433,234,630.15
  购建固定资产、无形资产和其他长期资产支付的现金1,612,196,921.121,124,571,482.54729,965,333.272,400,874,817.19
  投资支付的现金49,914,249,00036,028,414,84016,032,179,00045,933,887,000
  取得子公司及其他营业单位支付的现金656,284,741626,709,265.2618,657,072.8485,292,225.34
  支付其他与投资活动有关的现金1,416,500,364.131,151,755,000650,718,8401,597,200,887.93
  投资活动现金流出小计53,599,231,026.2538,931,450,587.817,431,520,246.1150,017,254,930.46
  投资活动产生的现金流量净额-790,307,953.71-1,240,265,624.86-972,937,405.01415,979,699.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金7,378,175.77,378,175.77,378,175.786,196,122.6
  取得借款收到的现金48,090,270,678.1535,773,622,565.6820,071,815,783.1261,928,229,561.85
  发行债券收到的现金7,997,083,333.335,997,825,0002,998,941,666.6711,997,222,500.01
  收到其他与筹资活动有关的现金198,437,899.47176,698,086.4174,562,727.69137,374,213.51
  筹资活动现金流入小计56,293,170,086.6541,955,523,827.7823,252,698,353.1874,149,022,397.97
  偿还债务支付的现金52,938,358,758.1136,315,299,38818,625,809,410.4570,102,029,449.94
  分配股利、利润或偿付利息支付的现金3,133,071,878.371,347,824,733.59590,654,622.244,309,892,169.51
  其中:子公司支付给少数股东的股利、利润758,979,753.81488,040,452.9183,402,958.44706,216,464.59
  支付其他与筹资活动有关的现金775,374,455.43539,022,568.43172,025,454.51,601,031,157.18
  筹资活动现金流出小计56,846,805,091.9138,202,146,690.0219,388,489,487.1976,012,952,776.63
  筹资活动产生的现金流量净额-553,635,005.263,753,377,137.763,864,208,865.99-1,863,930,378.66
四、汇率变动对现金及现金等价物的影响-11,454,659.07-13,772,678.984,038,703.532,156,741.31
五、现金及现金等价物净增加额994,412,547.553,488,595,822.81690,994,561.34,381,463,793.67
  加:期初现金及现金等价物余额31,881,272,794.8731,881,272,794.8731,881,272,794.8727,499,809,001.2
  期末现金及现金等价物余额32,875,685,342.4235,369,868,617.6832,572,267,356.1731,881,272,794.87
补充资料:
  净利润-4,994,784,030.29-5,870,011,314.88
  资产减值准备-410,078,463.89-614,373,564.47
  固定资产和投资性房地产折旧-767,496,142.84-1,294,305,848.92
  无形资产摊销-255,283,712.67-399,940,491.39
  长期待摊费用摊销-98,405,948.12-191,100,283.87
  处置固定资产、无形资产和其他长期资产的损失--39,986,393.32--187,967,998.85
  公允价值变动损失--75,751,833.73--203,853,796.87
  财务费用-894,866,769.55-1,837,342,811.14
  投资损失--3,353,837,518.88--593,000,866.77
  递延所得税-572,280,216.64--110,038,272.1
  其中:递延所得税资产减少--41,775,560.74-89,329,045.05
    递延所得税负债增加-614,055,777.38--199,367,317.15
  存货的减少--727,190,985.67--2,297,647,988.62
  经营性应收项目的减少--7,208,369,490.15--4,041,023,805.03
  经营性应付项目的增加-3,633,443,202.94-2,103,001,583.06
  现金的期末余额-35,369,868,617.68-31,881,272,794.87
  减:现金的期初余额-31,881,272,794.87-27,499,809,001.2
  现金及现金等价物的净增加额-3,488,595,822.81-4,381,463,793.67
公告日期2025-10-312025-08-292025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑